,Set,NGenes,Direction,PValue,FDR
1,WP_SMALL_LIGAND_GPCRS,7,Up,8.13907286449094e-06,0.00537059083421156
2,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,1.85052738148397e-05,0.00537059083421156
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,1.96006964752247e-05,0.00537059083421156
4,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,3.08660427514128e-05,0.00634297178541534
5,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Up,0.000108339451445445,0.0162691003523201
6,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.000118752557316205,0.0162691003523201
7,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.000370937140992725,0.0435586185565743
8,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.000453426190392227,0.0465895410628013
9,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.000610514528458574,0.0557603269325498
10,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.000836252798152891,0.0638138335367439
11,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.000853956409859104,0.0638138335367439
12,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00107419682340607,0.0735824824033161
13,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Up,0.00125776987078978,0.0795297564453227
14,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Up,0.00143605769545954,0.0843171018334102
15,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,20,Up,0.0015998580386104,0.0876722205158498
16,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.00178979527162813,0.0919507320798953
17,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Up,0.0031036096590008,0.142720827602932
18,WP_PEPTIDE_GPCRS,15,Up,0.0031252735971445,0.142720827602932
19,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.00348121730600863,0.148796281127316
20,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.00362034747268408,0.148796281127316
21,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.00403987301893721,0.158132172455542
22,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.0045128445628365,0.168616283211436
23,WP_MEVALONATE_PATHWAY,7,Up,0.00499186734777818,0.178404998255377
24,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.00545398230064546,0.186798893797107
25,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.00584218141783865,0.192090925018535
26,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.006102101369235,0.19292028175043
27,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.00700635181227285,0.213304488506974
28,WP_OSTEOBLAST_SIGNALING,3,Up,0.00756727525816304,0.21521756208543
29,WP_CHOLESTEROL_METABOLISM,52,Up,0.00759283369887769,0.21521756208543
30,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.00791296032372838,0.216815112870158
31,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.00956307729910101,0.25357579160842
32,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.013202847224245,0.339148138072793
33,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.0138263741321497,0.34440241020082
34,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.0147546495133612,0.350854881991878
35,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.0152738378608803,0.350854881991878
36,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.0153659072405202,0.350854881991878
37,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.0170881984220346,0.366198265085787
38,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0175065820842641,0.366198265085787
39,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.0176544197716788,0.366198265085787
40,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.0178198669141502,0.366198265085787
41,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Up,0.0208276106948037,0.417568194905577
42,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.0220602104830429,0.431749833739555
43,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.0230043288733073,0.439757170554852
44,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.0253312701271455,0.456960396928705
45,WP_BENZENE_METABOLISM,3,Up,0.0260952818497008,0.456960396928705
46,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0261290552125767,0.456960396928705
47,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.0269182246062025,0.456960396928705
48,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.0270401837397578,0.456960396928705
49,WP_CREATINE_PATHWAY,2,Down,0.0273443392550507,0.456960396928705
50,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.0281891687223266,0.456960396928705
51,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.0287184918330988,0.456960396928705
52,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Up,0.0289074703653195,0.456960396928705
53,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0308500688888844,0.466180235222418
54,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Up,0.0311810908488358,0.466180235222418
55,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.0311921081961472,0.466180235222418
56,WP_MEASLES_VIRUS_INFECTION,102,Up,0.0320650538143316,0.466253584701358
57,WP_IL7_SIGNALING,23,Up,0.0323314529537438,0.466253584701358
58,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.0357784385045759,0.49789981542264
59,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.0366614393726633,0.49789981542264
60,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.0368796407034529,0.49789981542264
61,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.0373595968427504,0.49789981542264
62,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Up,0.0375544872946517,0.49789981542264
63,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Up,0.038181963829105,0.498183718532132
64,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0393161452863323,0.503618864484346
65,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.0398238761453558,0.503618864484346
66,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.0408950884871436,0.509329738430788
67,WP_NRF2_PATHWAY,73,Up,0.0432734041062018,0.530906539929819
68,WP_NRXN1_DELETION_SYNDROME,2,Down,0.0445974110517393,0.538908437330899
69,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.0468614246317775,0.538908437330899
70,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.0469178968116975,0.538908437330899
71,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.0470335910532138,0.538908437330899
72,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.0472036587443123,0.538908437330899
73,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0497573463861864,0.545453266477358
74,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.0500298714260671,0.545453266477358
75,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0509538069845793,0.545453266477358
76,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.0516395841525293,0.545453266477358
77,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.0516442425807857,0.545453266477358
78,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.0523348833596969,0.545453266477358
79,WP_GPR40_PATHWAY,8,Down,0.0524805507934482,0.545453266477358
80,WP_IDO_METABOLIC_PATHWAY,8,Down,0.0533600839851439,0.545453266477358
81,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0544392143953668,0.545453266477358
82,WP_CANCER_PATHWAYS,308,Up,0.0553569356437931,0.545453266477358
83,WP_NEURAL_CREST_DIFFERENTIATION,40,Up,0.055689708441441,0.545453266477358
84,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.0561434771262286,0.545453266477358
85,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.0564033183097024,0.545453266477358
86,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,23,Up,0.0585584733091937,0.559710058839037
87,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.0603921813994342,0.56874909562398
88,WP_G13_SIGNALING,29,Up,0.0609251290883218,0.56874909562398
89,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.0627976541006601,0.56874909562398
90,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,21,Up,0.0629576410837484,0.56874909562398
91,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.0629637076664017,0.56874909562398
92,WP_NOTCH_SIGNALING_WP268,36,Up,0.0643296312505864,0.574771270521543
93,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Up,0.0672729848896443,0.594606382572985
94,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0689050036910094,0.595040776467725
95,WP_TAMOXIFEN_METABOLISM,2,Down,0.0696210926002955,0.595040776467725
96,WP_ACUTE_VIRAL_MYOCARDITIS,67,Up,0.069991274936429,0.595040776467725
97,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.0704122065757638,0.595040776467725
98,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.0711639168203348,0.595040776467725
99,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.0717221602661172,0.595040776467725
100,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.0728538343772976,0.595040776467725
101,WP_VEGFAVEGFR2_SIGNALING,341,Up,0.0731132827533336,0.595040776467725
102,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.0764966968021084,0.602383074611671
103,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,59,Down,0.0770592974613647,0.602383074611671
104,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.0776299853051738,0.602383074611671
105,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,37,Down,0.0776358890829534,0.602383074611671
106,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Up,0.0782733179830681,0.602383074611671
107,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.0784123953569937,0.602383074611671
108,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Up,0.0830160093479119,0.627022178031284
109,WP_NEPHROGENESIS,4,Down,0.0831452766489173,0.627022178031284
110,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.0860506016722222,0.643032677950606
111,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.0888436353901437,0.654615713596486
112,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.0898507593063052,0.654615713596486
113,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.0915415151102577,0.654615713596486
114,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.092808147846127,0.654615713596486
115,WP_GPCRS_OTHER,14,Down,0.0942422509573297,0.654615713596486
116,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.0963082691506869,0.654615713596486
117,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0963511346772925,0.654615713596486
118,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.0965180706368955,0.654615713596486
119,WP_DOPAMINE_METABOLISM,7,Up,0.0968522573407253,0.654615713596486
120,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.0970066179801891,0.654615713596486
121,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.0971362769581747,0.654615713596486
122,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Up,0.0971570767138337,0.654615713596486
123,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.101561461628853,0.676540446232504
124,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.102839501250143,0.676540446232504
125,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.103942571775002,0.676540446232504
126,WP_PDGF_PATHWAY,36,Up,0.103997740235655,0.676540446232504
127,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.105750354328648,0.676540446232504
128,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.106286955689561,0.676540446232504
129,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Up,0.106303750857311,0.676540446232504
130,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.106995447701004,0.676540446232504
131,WP_BREAST_CANCER_PATHWAY,87,Up,0.112407990936363,0.679851712527351
132,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.113948874968508,0.679851712527351
133,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.114008678470445,0.679851712527351
134,WP_ENDOMETRIAL_CANCER,48,Up,0.11401651815238,0.679851712527351
135,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.114751978692754,0.679851712527351
136,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.114969903606964,0.679851712527351
137,WP_LUNG_PATHOLOGY_OF_COVID19,16,Up,0.115533581094872,0.679851712527351
138,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.116671228860918,0.679851712527351
139,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Down,0.117118164862093,0.679851712527351
140,WP_AGERAGE_PATHWAY,54,Up,0.117123012804072,0.679851712527351
141,WP_HEPATITIS_B_INFECTION,116,Up,0.11762953099531,0.679851712527351
142,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.118876386551985,0.679851712527351
143,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.119722250271643,0.679851712527351
144,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.121498543006994,0.679851712527351
145,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.121711891986208,0.679851712527351
146,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.122508679238108,0.679851712527351
147,WP_CHEMOKINE_SIGNALING,109,Up,0.122700691301579,0.679851712527351
148,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.122937580038922,0.679851712527351
149,WP_IL9_SIGNALING,15,Up,0.123233461273206,0.679851712527351
150,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,72,Up,0.12445141854389,0.681993773620515
151,WP_SPHINGOLIPID_PATHWAY,21,Up,0.12897083891372,0.685392754267451
152,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.129056419614631,0.685392754267451
153,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.129958259655039,0.685392754267451
154,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.130861250767227,0.685392754267451
155,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.131466500138391,0.685392754267451
156,WP_ENDOTHELIN_PATHWAYS,13,Up,0.131585772812623,0.685392754267451
157,WP_PRION_DISEASE_PATHWAY,28,Up,0.132003254979162,0.685392754267451
158,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.13226563552802,0.685392754267451
159,WP_SMALL_CELL_LUNG_CANCER,71,Up,0.132575970715967,0.685392754267451
160,WP_IL5_SIGNALING,37,Up,0.135739370346453,0.687512689808862
161,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.13686584882911,0.687512689808862
162,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.138111700608593,0.687512689808862
163,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.138177456725138,0.687512689808862
164,WP_RETINOL_METABOLISM,6,Up,0.139553842905823,0.687512689808862
165,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.139691404688646,0.687512689808862
166,WP_THERMOGENESIS,73,Up,0.14075688239342,0.687512689808862
167,WP_RAC1PAK1P38MMP2_PATHWAY,50,Up,0.140907208416631,0.687512689808862
168,WP_CHOLESTASIS,9,Up,0.142981317625164,0.687512689808862
169,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.143829052870077,0.687512689808862
170,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.145746017811503,0.687512689808862
171,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.146135099785383,0.687512689808862
172,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.146763683480244,0.687512689808862
173,WP_GLUTATHIONE_METABOLISM,10,Up,0.147431451065605,0.687512689808862
174,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.15062192074928,0.687512689808862
175,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.150622993618971,0.687512689808862
176,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.151078429061789,0.687512689808862
177,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Up,0.151888071068768,0.687512689808862
178,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.152057000961523,0.687512689808862
179,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.152809025506336,0.687512689808862
180,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.152994546180702,0.687512689808862
181,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.154322239319585,0.687512689808862
182,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.154422780611111,0.687512689808862
183,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.154508317256088,0.687512689808862
184,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.154866729296766,0.687512689808862
185,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.155906818464483,0.687512689808862
186,WP_PURINE_METABOLISM,10,Down,0.155987882491761,0.687512689808862
187,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.157942592302852,0.687512689808862
188,WP_ASPIRIN_AND_MIRNAS,8,Down,0.158511137935114,0.687512689808862
189,WP_IL19_SIGNALING,20,Up,0.159654998193096,0.687512689808862
190,WP_FOCAL_ADHESION,118,Up,0.159684296144496,0.687512689808862
191,WP_KCNQ2RELATED_EPILEPSIES,12,Down,0.159750515515198,0.687512689808862
192,WP_ALZHEIMERS_DISEASE,184,Up,0.164668645963601,0.696733387359144
193,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.164668645963601,0.696733387359144
194,WP_MONOAMINE_GPCRS,3,Up,0.165126395579519,0.696733387359144
195,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.165999374613188,0.696733387359144
196,WP_GLUCURONIDATION,7,Up,0.166923573616367,0.696733387359144
197,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.167761673904251,0.696733387359144
198,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Up,0.170053156209864,0.696733387359144
199,WP_PROTEASOME_DEGRADATION,57,Up,0.170272506024514,0.696733387359144
200,WP_FERROPTOSIS,51,Up,0.170288485220691,0.696733387359144
201,WP_MELANOMA,54,Up,0.170569630200556,0.696733387359144
202,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,66,Up,0.17130143827742,0.696733387359144
203,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.172064328021784,0.696733387359144
204,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Up,0.174095018104437,0.701500514126703
205,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.17727705437508,0.708894230098729
206,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.177971442469401,0.708894230098729
207,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.178517160134352,0.708894230098729
208,WP_RAS_SIGNALING,116,Up,0.181234106388173,0.70984145282616
209,WP_MIRNA_BIOGENESIS,6,Up,0.181904069501524,0.70984145282616
210,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,17,Up,0.183854730535084,0.70984145282616
211,WP_CCL18_SIGNALING,21,Up,0.184069331317288,0.70984145282616
212,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.184260207670123,0.70984145282616
213,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.185520519755192,0.70984145282616
214,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.185544916645433,0.70984145282616
215,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Up,0.185664126955747,0.70984145282616
216,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.191437739409969,0.723203095162272
217,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.191473662874808,0.723203095162272
218,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.191798387768096,0.723203095162272
219,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.194129966577582,0.725389721455253
220,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Up,0.195288955388203,0.725389721455253
221,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Up,0.197394174542052,0.725389721455253
222,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.198425453330072,0.725389721455253
223,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.199780973204405,0.725389721455253
224,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.199807489113871,0.725389721455253
225,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.200717719275784,0.725389721455253
226,WP_MAPK_SIGNALING,163,Up,0.200731909604686,0.725389721455253
227,WP_TP53_NETWORK,16,Down,0.201086190348543,0.725389721455253
228,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.202067763464396,0.725389721455253
229,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.202085457680356,0.725389721455253
230,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.204457452476291,0.729016979963829
231,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Up,0.205385519697009,0.729016979963829
232,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.206483095602248,0.729016979963829
233,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.206643499186828,0.729016979963829
234,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.209329038930621,0.733036997352687
235,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.209923591598759,0.733036997352687
236,WP_RETINOBLASTOMA_GENE_IN_CANCER,71,Up,0.210458310675467,0.733036997352687
237,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.212437034182934,0.736806928685112
238,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.215232791525452,0.743367036276981
239,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.217656764149084,0.747507556614777
240,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.219092968157129,0.747507556614777
241,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Down,0.219590919441196,0.747507556614777
242,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.220069134672477,0.747507556614777
243,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.223558875943524,0.749280264675015
244,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.223614946984014,0.749280264675015
245,WP_CAMKK2_PATHWAY,29,Up,0.224977490881731,0.749280264675015
246,WP_BURN_WOUND_HEALING,60,Down,0.225918076996127,0.749280264675015
247,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.226620750511973,0.749280264675015
248,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.22732009460702,0.749280264675015
249,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.227999315920668,0.749280264675015
250,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.228282053916051,0.749280264675015
251,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.228794825344804,0.749280264675015
252,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.23037400553731,0.749802411334252
253,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.230778601055433,0.749802411334252
254,WP_IL2_SIGNALING,37,Up,0.233336488166786,0.754132213927114
255,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.233946124758411,0.754132213927114
256,WP_MACROPHAGE_MARKERS,9,Down,0.236859652034949,0.756524958478921
257,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.236916330525187,0.756524958478921
258,WP_PDGFRBETA_PATHWAY,27,Up,0.238775799999121,0.756524958478921
259,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.239570645034169,0.756524958478921
260,WP_TAR_SYNDROME,44,Up,0.241347582470839,0.756524958478921
261,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.242411992995057,0.756524958478921
262,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.245558091065742,0.756524958478921
263,WP_COMPLEMENT_SYSTEM,52,Down,0.246521860001435,0.756524958478921
264,WP_NOTCH_SIGNALING_WP61,49,Up,0.246790790951739,0.756524958478921
265,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.247065481536016,0.756524958478921
266,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.247398167987498,0.756524958478921
267,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.248286162821452,0.756524958478921
268,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.248502632051898,0.756524958478921
269,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.248977871417961,0.756524958478921
270,WP_BENZOAPYRENE_METABOLISM,5,Down,0.249915861469257,0.756524958478921
271,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.250356118010833,0.756524958478921
272,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.251098715782844,0.756524958478921
273,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Up,0.252140156446709,0.756524958478921
274,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Down,0.256927110882848,0.756524958478921
275,WP_IRON_METABOLISM_DISORDERS,13,Up,0.256953188399589,0.756524958478921
276,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.25707433976554,0.756524958478921
277,WP_GPCRS_CLASS_A_RHODOPSINLIKE,44,Up,0.258690394093568,0.756524958478921
278,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.260688083941808,0.756524958478921
279,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.260898226026198,0.756524958478921
280,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,142,Up,0.261501544686738,0.756524958478921
281,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.2617862341821,0.756524958478921
282,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.262940095412884,0.756524958478921
283,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.263310042367671,0.756524958478921
284,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.264391380714123,0.756524958478921
285,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.265469146233082,0.756524958478921
286,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.266616191121866,0.756524958478921
287,WP_KREBS_CYCLE_DISORDERS,11,Up,0.266917600228501,0.756524958478921
288,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.267098876283593,0.756524958478921
289,WP_NEPHROTIC_SYNDROME,28,Up,0.267690745702408,0.756524958478921
290,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.270309536182106,0.756524958478921
291,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Up,0.270650474461254,0.756524958478921
292,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.271525456925323,0.756524958478921
293,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.272023146709678,0.756524958478921
294,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.272023146709678,0.756524958478921
295,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Up,0.272450231926227,0.756524958478921
296,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.274877798654696,0.756524958478921
297,WP_PROSTAGLANDIN_SIGNALING,23,Up,0.275165314632344,0.756524958478921
298,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.276316531184183,0.756524958478921
299,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.276894830772304,0.756524958478921
300,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Up,0.27692906745728,0.756524958478921
301,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Up,0.278740309033594,0.756524958478921
302,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.279216685254859,0.756524958478921
303,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.280248381098523,0.756524958478921
304,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,13,Up,0.281052941253527,0.756524958478921
305,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Up,0.282244551192681,0.756524958478921
306,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.283839746779746,0.756524958478921
307,WP_CELLULAR_PROTEOSTASIS,6,Down,0.284284444034658,0.756524958478921
308,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.285089301962237,0.756524958478921
309,WP_KININKALLIKREIN_PATHWAY,2,Up,0.285263577527005,0.756524958478921
310,WP_COMPLEMENT_ACTIVATION,13,Down,0.285307466093024,0.756524958478921
311,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,96,Up,0.286780759393428,0.757986444441795
312,WP_UROTENSINIIMEDIATED_SIGNALING,50,Up,0.288549429425502,0.75894076101889
313,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.28898839196948,0.75894076101889
314,WP_MAPK_CASCADE,30,Up,0.29013312280279,0.759520467974181
315,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.292191150831887,0.761648267817641
316,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Up,0.293422856303457,0.761648267817641
317,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.29458238461256,0.761648267817641
318,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.295370875476445,0.761648267817641
319,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.296641904139478,0.761648267817641
320,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Up,0.297745195620065,0.761648267817641
321,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.297769637197102,0.761648267817641
322,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.29866992921549,0.761648267817641
323,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.300583360726884,0.761648267817641
324,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.301026984192115,0.761648267817641
325,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.302060268691974,0.761648267817641
326,WP_NONSMALL_CELL_LUNG_CANCER,59,Up,0.30206488480359,0.761648267817641
327,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Up,0.304456876541672,0.763250381982545
328,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.30455733003683,0.763250381982545
329,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.312707619514695,0.780544637746948
330,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Down,0.314077096761475,0.780544637746948
331,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.314306904007591,0.780544637746948
332,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Up,0.317222613959875,0.782343913976791
333,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.31804679093931,0.782343913976791
334,WP_GASTRIN_SIGNALING,92,Up,0.318822135110744,0.782343913976791
335,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.318838456426065,0.782343913976791
336,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Up,0.321870618629382,0.787242928813261
337,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.322750446484269,0.787242928813261
338,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.32514744832582,0.789681494732884
339,WP_NAD_METABOLISM,12,Up,0.325671565346043,0.789681494732884
340,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.327451005136937,0.790386749015828
341,WP_MRNA_PROCESSING,124,Down,0.327885500504133,0.790386749015828
342,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.330327289776499,0.793365001849757
343,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Down,0.331051332888645,0.793365001849757
344,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.334198837600043,0.795653931522714
345,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.334422603804428,0.795653931522714
346,WP_NPHP1_DELETION_SYNDROME,10,Up,0.334910292344111,0.795653931522714
347,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.338735098307816,0.797233927813336
348,WP_TRYPTOPHAN_METABOLISM,19,Up,0.33944889662824,0.797233927813336
349,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.339462603741758,0.797233927813336
350,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Up,0.341022001663371,0.797233927813336
351,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.341394577360455,0.797233927813336
352,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.341394577360455,0.797233927813336
353,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.342810773104406,0.798212053107286
354,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.344333706274462,0.798212053107286
355,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.344726616609594,0.798212053107286
356,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.346612368299637,0.800136459410532
357,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.348397234977007,0.800136459410532
358,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.348477922711643,0.800136459410532
359,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.350213625305191,0.801881894152832
360,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.35148021140129,0.802546482699611
361,WP_COPPER_HOMEOSTASIS,40,Up,0.352813536174127,0.803359353836931
362,WP_DNA_MISMATCH_REPAIR,21,Down,0.355419878850141,0.807058398935957
363,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Up,0.359561760277434,0.811041868346783
364,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.361003810464422,0.811041868346783
365,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.361803564320754,0.811041868346783
366,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.36193830411316,0.811041868346783
367,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.362107500831228,0.811041868346783
368,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Up,0.36399706623071,0.813058664243596
369,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.365886828692923,0.815064967982609
370,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.367115389936212,0.815211659628161
371,WP_AXON_GUIDANCE,37,Up,0.368092661119625,0.815211659628161
372,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Up,0.36892790435727,0.815211659628161
373,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.372116299780354,0.818616310714693
374,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Up,0.372460462539289,0.818616310714693
375,WP_VITAMIN_B12_METABOLISM,27,Down,0.373868530984345,0.819519819917684
376,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.375868163138872,0.821711782181258
377,WP_ENERGY_METABOLISM,41,Up,0.377572665275053,0.823248622960461
378,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.379918889597414,0.826172823410249
379,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.382307282958079,0.828681476930108
380,WP_NUCLEAR_RECEPTORS,20,Down,0.383088760624624,0.828681476930108
381,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.384420732937893,0.829380163976243
382,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.386954923990559,0.831099223034623
383,WP_P38_MAPK_SIGNALING,31,Up,0.388053221639941,0.831099223034623
384,WP_HEART_DEVELOPMENT,16,Up,0.388250731928583,0.831099223034623
385,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.389659082842657,0.831133180708049
386,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.392674552493122,0.831133180708049
387,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Up,0.394099213534212,0.831133180708049
388,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.395372958865105,0.831133180708049
389,WP_HIPPO_SIGNALING_REGULATION,45,Up,0.395638031686573,0.831133180708049
390,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,78,Up,0.398259506710089,0.831133180708049
391,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Up,0.398711210536468,0.831133180708049
392,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.399931764195657,0.831133180708049
393,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.4001144763353,0.831133180708049
394,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.400478915584553,0.831133180708049
395,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.401798517969422,0.831133180708049
396,WP_PI3KAKT_SIGNALING,180,Up,0.402019546765204,0.831133180708049
397,WP_BDNFTRKB_SIGNALING,26,Up,0.402256280845968,0.831133180708049
398,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.402422148323362,0.831133180708049
399,WP_SPINAL_CORD_INJURY,67,Up,0.403512169803953,0.831295748317918
400,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.404692170108465,0.831642409572896
401,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.406464564767104,0.833201676405384
402,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.408695775837417,0.834371432417183
403,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.410756744359252,0.834371432417183
404,WP_HYPERTROPHY_MODEL,14,Down,0.41102054749578,0.834371432417183
405,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Up,0.411095413782189,0.834371432417183
406,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.415084951006387,0.840393669278942
407,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.416230631594459,0.840642700664977
408,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.419144287416228,0.842655114343536
409,WP_VITAMIN_D_METABOLISM,6,Up,0.419277301419107,0.842655114343536
410,WP_DNA_DAMAGE_RESPONSE,59,Up,0.421719317628245,0.845495802659554
411,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.425222187676305,0.848756416245212
412,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.425410758507333,0.848756416245212
413,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.427238180208511,0.850338460366577
414,WP_LEPTIN_SIGNALING,69,Up,0.430649090771327,0.854555343890827
415,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Down,0.431734278100382,0.854555343890827
416,WP_PLEURAL_MESOTHELIOMA,257,Up,0.432475697151562,0.854555343890827
417,WP_METABOLIC_EPILEPTIC_DISORDERS,56,Down,0.434176399930195,0.854769309609336
418,WP_TGFB_SMAD_SIGNALING,8,Up,0.434663712185769,0.854769309609336
419,WP_BARDETBIEDL_SYNDROME,65,Down,0.438752692917336,0.859309257277978
420,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Down,0.439063124156631,0.859309257277978
421,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.440559741700759,0.860190279520247
422,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.44191144645485,0.860784855416793
423,WP_G_PROTEIN_SIGNALING,61,Up,0.445889635673,0.86471504224103
424,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.446033063151091,0.86471504224103
425,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.450719648029984,0.871744825130934
426,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.453220450641368,0.874383765436932
427,WP_WNT_SIGNALING_WP363,38,Up,0.454404172449102,0.874383765436932
428,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.455275245263999,0.874383765436932
429,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Up,0.458457363146921,0.878442779736058
430,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.460760745575194,0.878494812256476
431,WP_OPIOID_RECEPTOR_PATHWAYS,26,Up,0.462767365213622,0.878494812256476
432,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.46313011049848,0.878494812256476
433,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.4646198373344,0.878494812256476
434,WP_FOXA2_PATHWAY,9,Down,0.46635438652066,0.878494812256476
435,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.466667161729297,0.878494812256476
436,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Up,0.467510131720221,0.878494812256476
437,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.468203756090681,0.878494812256476
438,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.471164630476768,0.878494812256476
439,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.471411672178255,0.878494812256476
440,WP_HIPPOYAP_SIGNALING,16,Up,0.472175907188088,0.878494812256476
441,WP_MTHFR_DEFICIENCY,18,Down,0.477521631998063,0.878494812256476
442,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.478831358037989,0.878494812256476
443,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.480978917560776,0.878494812256476
444,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.481456345768023,0.878494812256476
445,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.481548469872962,0.878494812256476
446,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.481648644867642,0.878494812256476
447,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.482013741250978,0.878494812256476
448,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Up,0.48246598460213,0.878494812256476
449,WP_ENDOCHONDRAL_OSSIFICATION,27,Up,0.482591390557666,0.878494812256476
450,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Up,0.482591390557666,0.878494812256476
451,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.483005562470126,0.878494812256476
452,WP_PYRIMIDINE_METABOLISM,71,Down,0.483065273892855,0.878494812256476
453,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Up,0.485867193112468,0.878563093553528
454,WP_IRINOTECAN_PATHWAY,5,Down,0.487117657642535,0.878563093553528
455,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.488345228519672,0.878563093553528
456,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.489591215541418,0.878563093553528
457,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.492204724276188,0.878563093553528
458,WP_METHYLATION_PATHWAYS,5,Up,0.492841714647233,0.878563093553528
459,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.493374245288571,0.878563093553528
460,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.493536968314396,0.878563093553528
461,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Up,0.493967460489621,0.878563093553528
462,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Up,0.494696634239231,0.878563093553528
463,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.494859747342194,0.878563093553528
464,WP_AMINO_ACID_METABOLISM,59,Up,0.498637073233701,0.881653565594375
465,WP_PRIMARY_OVARIAN_INSUFFICIENCY,91,Up,0.498745630172001,0.881653565594375
466,WP_NUCLEOTIDE_GPCRS,5,Down,0.501158431730876,0.882594503439098
467,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.501425344411264,0.882594503439098
468,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.50675933561795,0.887369340469626
469,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,30,Down,0.507704479446579,0.887369340469626
470,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.508989644283746,0.887369340469626
471,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.50961704504991,0.887369340469626
472,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.509822638684941,0.887369340469626
473,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.510615204430819,0.887369340469626
474,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.511973276771928,0.887852391363976
475,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Up,0.51442917334537,0.888801298634469
476,WP_HISTONE_MODIFICATIONS,37,Down,0.51468299045013,0.888801298634469
477,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.516655224380426,0.889119377865823
478,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.517030489805187,0.889119377865823
479,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.520581945726719,0.89240922392904
480,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.521114875287031,0.89240922392904
481,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.523726368392875,0.892697642081223
482,WP_CELL_CYCLE,95,Up,0.527212264271349,0.892697642081223
483,WP_IL6_SIGNALING,40,Up,0.527237189487899,0.892697642081223
484,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.527734247939484,0.892697642081223
485,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.528399145845076,0.892697642081223
486,WP_EGFEGFR_SIGNALING,138,Up,0.528922726562229,0.892697642081223
487,WP_RETT_SYNDROME,30,Up,0.529632745064795,0.892697642081223
488,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.530592870360301,0.892697642081223
489,WP_GLYOXYLATE_METABOLISM,5,Up,0.531057356420582,0.892697642081223
490,WP_BLOOD_CLOTTING_CASCADE,7,Up,0.534892717712522,0.896222686656577
491,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.535334962467614,0.896222686656577
492,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.538985183644266,0.897546937771278
493,WP_B_CELL_RECEPTOR_SIGNALING,85,Down,0.540484871300655,0.897546937771278
494,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.540847637477183,0.897546937771278
495,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.542291693244058,0.897546937771278
496,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.543249044607817,0.897546937771278
497,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.543671094528311,0.897546937771278
498,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.543903364261701,0.897546937771278
499,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.546242226044646,0.897546937771278
500,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.547014273559037,0.897546937771278
501,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.547045031415341,0.897546937771278
502,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.54828305266992,0.897786193814092
503,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.549608732520566,0.898102507811293
504,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.551621600144713,0.898102507811293
505,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.553163375903132,0.898102507811293
506,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.554661162251403,0.898102507811293
507,WP_IL11_SIGNALING,40,Up,0.555067758058721,0.898102507811293
508,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.55669811038159,0.898102507811293
509,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.556740038192277,0.898102507811293
510,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Down,0.561829127905959,0.898102507811293
511,WP_JOUBERT_SYNDROME,70,Up,0.562041764116003,0.898102507811293
512,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.56261236837175,0.898102507811293
513,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.563278865483826,0.898102507811293
514,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.5645603167372,0.898102507811293
515,WP_KLEEFSTRA_SYNDROME,25,Down,0.565139663277552,0.898102507811293
516,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.565355551281514,0.898102507811293
517,WP_TRANSSULFURATION_PATHWAY,8,Down,0.566480648728931,0.898102507811293
518,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.569775548813117,0.898102507811293
519,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.569853699508985,0.898102507811293
520,WP_PURINERGIC_SIGNALING,14,Up,0.570219141439298,0.898102507811293
521,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.570321685102551,0.898102507811293
522,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.57032786992396,0.898102507811293
523,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Down,0.57188065510313,0.89882580974144
524,WP_ULCERATIVE_COLITIS_SIGNALING,13,Up,0.573548358060549,0.899216510603921
525,WP_COMPLEMENT_AND_COAGULATION_CASCADES,27,Up,0.575411051797643,0.899216510603921
526,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,27,Up,0.575411051797643,0.899216510603921
527,WP_CYTOSINE_METHYLATION,7,Up,0.576933564584042,0.899884990679473
528,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.579227685114093,0.900728083733223
529,WP_TNFALPHA_SIGNALING,85,Up,0.579665640261405,0.900728083733223
530,WP_OXIDATIVE_DAMAGE_RESPONSE,35,Down,0.582111773755067,0.901705161008087
531,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.582488370432231,0.901705161008087
532,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Up,0.585044207451684,0.90333477876329
533,WP_WNT_SIGNALING_WP428,60,Up,0.585922383789287,0.90333477876329
534,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.590907519963852,0.90333477876329
535,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.591246001025035,0.90333477876329
536,WP_DNA_REPLICATION,35,Down,0.591627546843102,0.90333477876329
537,WP_IL3_SIGNALING,46,Up,0.593565293986075,0.90333477876329
538,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.593914489006874,0.90333477876329
539,WP_ESTROGEN_SIGNALING,21,Up,0.593946496364663,0.90333477876329
540,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.594129090841781,0.90333477876329
541,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.594710245596434,0.90333477876329
542,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.595629501325673,0.90333477876329
543,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.59863108051678,0.904776182765753
544,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.599066532750121,0.904776182765753
545,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.599882018987026,0.904776182765753
546,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.601368572776139,0.90535708209155
547,WP_ANGIOGENESIS,14,Down,0.602697070035377,0.905698339248776
548,WP_OSTEOPONTIN_SIGNALING,11,Up,0.604739676683597,0.907109515025396
549,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.610286020114306,0.912259218837016
550,WP_OREXIN_RECEPTOR_PATHWAY,120,Down,0.610392421362967,0.912259218837016
551,WP_FRAGILE_X_SYNDROME,83,Up,0.615329465038026,0.91337799985747
552,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Up,0.615683784844089,0.91337799985747
553,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.617152352704812,0.91337799985747
554,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.619302224138482,0.91337799985747
555,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Up,0.621493682286701,0.91337799985747
556,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.621679442519497,0.91337799985747
557,WP_NEUROINFLAMMATION,10,Up,0.622139831502457,0.91337799985747
558,WP_PPARALPHA_PATHWAY,15,Up,0.622762999669963,0.91337799985747
559,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.623012414204506,0.91337799985747
560,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Up,0.623599070684453,0.91337799985747
561,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Up,0.624097061781157,0.91337799985747
562,WP_MALE_INFERTILITY,69,Down,0.624474982870923,0.91337799985747
563,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.626004643659009,0.913569031263487
564,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.627135519841739,0.913569031263487
565,WP_NETRINUNC5B_SIGNALING,36,Up,0.628518378947615,0.913569031263487
566,WP_SILDENAFIL_TREATMENT,11,Down,0.629051182110868,0.913569031263487
567,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.631988210309663,0.916215712300782
568,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.633986194578753,0.917302973248505
569,WP_ZINC_HOMEOSTASIS,24,Up,0.634970062990754,0.917302973248505
570,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.636835495747437,0.918383820183146
571,WP_LUNG_FIBROSIS,34,Up,0.639051888118129,0.919889730085292
572,WP_ARYLAMINE_METABOLISM,1,Up,0.640117914365921,0.919889730085292
573,WP_HUNGER_AND_SATIETY,2,Up,0.643618120573567,0.922453805754865
574,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.644497348643674,0.922453805754865
575,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.645268781397868,0.922453805754865
576,WP_FOLATE_METABOLISM,40,Down,0.647571978184889,0.924139177201351
577,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.650366716748655,0.925339504874855
578,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.650664518026357,0.925339504874855
579,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Up,0.656819936414413,0.932034714252556
580,WP_ATR_SIGNALING,10,Up,0.658117542857025,0.932034714252556
581,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Down,0.658773928200408,0.932034714252556
582,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.663623729190865,0.937282998960294
583,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.665329912707989,0.937824705836439
584,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.666803840507516,0.937824705836439
585,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.668379547409722,0.937824705836439
586,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.669106744741372,0.937824705836439
587,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.670109318984883,0.937824705836439
588,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.671038433124278,0.937824705836439
589,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,127,Up,0.673382276685928,0.937824705836439
590,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Up,0.674016266396358,0.937824705836439
591,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.675415271122013,0.937824705836439
592,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.676346678514853,0.937824705836439
593,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.676557239125314,0.937824705836439
594,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.679775515063048,0.940699450137754
595,WP_PREIMPLANTATION_EMBRYO,20,Down,0.681155414841863,0.941024791596658
596,WP_OVARIAN_INFERTILITY,21,Up,0.68257050570268,0.941397576657052
597,WP_PPAR_SIGNALING,39,Up,0.686580830238005,0.943787140920431
598,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.688635268672868,0.943787140920431
599,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.690202980686591,0.943787140920431
600,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.6902631849872,0.943787140920431
601,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.69107577692756,0.943787140920431
602,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.69285020826225,0.943787140920431
603,WP_POSTCOVID_NEUROINFLAMMATION,13,Up,0.69413718001434,0.943787140920431
604,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.694645107121418,0.943787140920431
605,WP_ONECARBON_METABOLISM,22,Up,0.699456216561343,0.943787140920431
606,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.700640602053768,0.943787140920431
607,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.701008901156694,0.943787140920431
608,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.70106766071202,0.943787140920431
609,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.70241319060065,0.943787140920431
610,WP_CILIARY_LANDSCAPE,184,Up,0.702565834268832,0.943787140920431
611,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Up,0.702569434898715,0.943787140920431
612,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.702946108716457,0.943787140920431
613,WP_ID_SIGNALING,12,Up,0.703821797304409,0.943787140920431
614,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.7105451468668,0.94601662045311
615,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.711251233843642,0.94601662045311
616,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.712562116208149,0.94601662045311
617,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.713510224879926,0.94601662045311
618,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.713658444700938,0.94601662045311
619,WP_ALLOGRAFT_REJECTION,52,Up,0.713859094710694,0.94601662045311
620,WP_SEROTONIN_AND_ANXIETY,6,Up,0.715119949539041,0.94601662045311
621,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.717297449887372,0.94601662045311
622,WP_5Q35_COPY_NUMBER_VARIATION,76,Down,0.717917957791142,0.94601662045311
623,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.71799057684701,0.94601662045311
624,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.718144003847617,0.94601662045311
625,WP_ACE_INHIBITOR_PATHWAY,3,Up,0.720616182724098,0.947054801964049
626,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.721236382031016,0.947054801964049
627,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.72428173369804,0.949536818340971
628,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.729165641101501,0.952384431918244
629,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.729878931466152,0.952384431918244
630,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Down,0.729929674097924,0.952384431918244
631,WP_AEROBIC_GLYCOLYSIS,10,Down,0.733858116454618,0.952972994134213
632,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.733858116454618,0.952972994134213
633,WP_MATRIX_METALLOPROTEINASES,8,Down,0.73461439582238,0.952972994134213
634,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.735018100098651,0.952972994134213
635,WP_ENDODERM_DIFFERENTIATION,82,Up,0.736281496242475,0.953107700647739
636,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.738546280618262,0.953193905919629
637,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.739071003049111,0.953193905919629
638,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.739987008214766,0.953193905919629
639,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Down,0.741259226956791,0.953193905919629
640,WP_KALLMANN_SYNDROME,11,Up,0.742146106798738,0.953193905919629
641,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Up,0.745660313160333,0.953990783625197
642,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.74600548125532,0.953990783625197
643,WP_BASE_EXCISION_REPAIR,29,Up,0.748082422831147,0.953990783625197
644,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.748119577870054,0.953990783625197
645,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.748569410508823,0.953990783625197
646,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Up,0.752367818698944,0.957347286332093
647,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.756649562046735,0.960077349643066
648,WP_TRANSLATION_FACTORS,49,Up,0.75684929752884,0.960077349643066
649,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.761286887473307,0.961632751833835
650,WP_ERBB_SIGNALING,67,Up,0.763592666997304,0.961632751833835
651,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.766131556371047,0.961632751833835
652,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.767978234576311,0.961632751833835
653,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.768241493279409,0.961632751833835
654,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.768372607865126,0.961632751833835
655,WP_FOXP3_IN_COVID19,10,Down,0.768387768324093,0.961632751833835
656,WP_PROLACTIN_SIGNALING,69,Down,0.76929556856132,0.961632751833835
657,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.769640237492468,0.961632751833835
658,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.76977414927818,0.961632751833835
659,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.77505798672024,0.965527492337639
660,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.775878034653116,0.965527492337639
661,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.777058091420611,0.965527492337639
662,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.777590267551724,0.965527492337639
663,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.780724501641487,0.966558942143002
664,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.780772673458581,0.966558942143002
665,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.784589629065729,0.968162952616576
666,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.785403274582185,0.968162952616576
667,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.78560181191637,0.968162952616576
668,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.790321976952888,0.97252195367556
669,WP_ADIPOGENESIS,87,Up,0.793557724915386,0.975044020748053
670,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.795088030612435,0.975466210691674
671,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Up,0.800567607425512,0.979191212333126
672,WP_SPINA_BIFIDA,10,Down,0.803853521281567,0.979191212333126
673,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.804363775348979,0.979191212333126
674,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Up,0.805011224617131,0.979191212333126
675,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Up,0.805252354115514,0.979191212333126
676,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.80527160527639,0.979191212333126
677,WP_AUTOPHAGY,27,Up,0.8148424215831,0.980185831320829
678,WP_ECTODERM_DIFFERENTIATION,77,Down,0.816701101647653,0.980185831320829
679,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.818460963443166,0.980185831320829
680,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.819698467720994,0.980185831320829
681,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Up,0.820603212713858,0.980185831320829
682,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.820641179962288,0.980185831320829
683,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.820681461696852,0.980185831320829
684,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.821742945011148,0.980185831320829
685,WP_DRAVET_SYNDROME,13,Down,0.822302487115863,0.980185831320829
686,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.826058382692163,0.980185831320829
687,WP_STEROID_BIOSYNTHESIS,2,Down,0.829186452543077,0.980185831320829
688,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.830544166223464,0.980185831320829
689,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.831082172096139,0.980185831320829
690,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.832979354804284,0.980185831320829
691,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Down,0.8339520614043,0.980185831320829
692,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.834399966249746,0.980185831320829
693,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Down,0.835543509102736,0.980185831320829
694,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.836241772238635,0.980185831320829
695,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.83790625072438,0.980185831320829
696,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.838259701893368,0.980185831320829
697,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.838259701893368,0.980185831320829
698,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Down,0.83914329240025,0.980185831320829
699,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.840220243361592,0.980185831320829
700,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.840236775254173,0.980185831320829
701,WP_IL4_SIGNALING,50,Down,0.841586009486436,0.980185831320829
702,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.842523743258302,0.980185831320829
703,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Down,0.842614495442379,0.980185831320829
704,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.842704191651935,0.980185831320829
705,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.849314531835179,0.980185831320829
706,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Down,0.851172416265825,0.980185831320829
707,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.856560651794028,0.980185831320829
708,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.856573981120397,0.980185831320829
709,WP_IL1_SIGNALING,53,Up,0.856974243003282,0.980185831320829
710,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.857410342057561,0.980185831320829
711,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.860744356181163,0.980185831320829
712,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.860887284653283,0.980185831320829
713,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.862830501490825,0.980185831320829
714,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.864093451461152,0.980185831320829
715,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Up,0.866262724955838,0.980185831320829
716,WP_SERINE_METABOLISM,5,Down,0.86680521255829,0.980185831320829
717,WP_RANKLRANK_SIGNALING,48,Down,0.867646751255762,0.980185831320829
718,WP_CILIOPATHIES,127,Down,0.86795466553562,0.980185831320829
719,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Up,0.868810785894834,0.980185831320829
720,WP_BLADDER_CANCER,29,Up,0.869131184982982,0.980185831320829
721,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Up,0.869757609974343,0.980185831320829
722,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.871424848504888,0.980185831320829
723,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.871670596366481,0.980185831320829
724,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.872176246383994,0.980185831320829
725,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,40,Down,0.872275791584573,0.980185831320829
726,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Up,0.872502802970838,0.980185831320829
727,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.873277919993107,0.980185831320829
728,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.876328960026204,0.980185831320829
729,WP_OSTEOCLAST_SIGNALING,9,Up,0.878589004640259,0.980185831320829
730,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.879250987738609,0.980185831320829
731,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.879947220934983,0.980185831320829
732,WP_IL26_SIGNALING,33,Up,0.880237425369003,0.980185831320829
733,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.882918629187328,0.980185831320829
734,WP_NRF2ARE_REGULATION,20,Up,0.883805639735096,0.980185831320829
735,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.883808236020855,0.980185831320829
736,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.885263103210289,0.980185831320829
737,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.887508639708727,0.980185831320829
738,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.887667760253857,0.980185831320829
739,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.889259289338364,0.980185831320829
740,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.889269990330215,0.980185831320829
741,WP_VITAMIN_B12_DISORDERS,9,Down,0.890456906189903,0.980185831320829
742,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.890773975415689,0.980185831320829
743,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.891829616452159,0.980185831320829
744,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.892241193008872,0.980185831320829
745,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Up,0.893056170174402,0.980185831320829
746,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.895052814759465,0.980185831320829
747,WP_HEME_BIOSYNTHESIS,8,Down,0.895052814759465,0.980185831320829
748,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.896522332810963,0.980185831320829
749,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.897792670265089,0.980185831320829
750,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.898302728916746,0.980185831320829
751,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Up,0.900282985382991,0.980185831320829
752,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.901193246015502,0.980185831320829
753,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.904499074353921,0.980185831320829
754,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.904536069841272,0.980185831320829
755,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Down,0.906784717521347,0.980185831320829
756,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.908070017258334,0.980185831320829
757,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.909866514964225,0.980185831320829
758,WP_ATM_SIGNALING,34,Down,0.911326393212685,0.980185831320829
759,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.912066856878827,0.980185831320829
760,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.912769488839369,0.980185831320829
761,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Up,0.913116781600464,0.980185831320829
762,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Up,0.914195961075867,0.980185831320829
763,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.914695980923614,0.980185831320829
764,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Down,0.91482024497196,0.980185831320829
765,WP_IL17_SIGNALING,25,Down,0.915814802783222,0.980185831320829
766,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.917003904066306,0.980185831320829
767,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.91846795591022,0.980185831320829
768,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.918835223417264,0.980185831320829
769,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.920010734186584,0.980185831320829
770,WP_IL18_SIGNALING,193,Up,0.920592088836629,0.980185831320829
771,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.920693412455755,0.980185831320829
772,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.922497019817372,0.980185831320829
773,WP_VALPROIC_ACID_PATHWAY,8,Down,0.925725494844564,0.980185831320829
774,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Up,0.926822337344695,0.980185831320829
775,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Up,0.927287372595857,0.980185831320829
776,WP_MONOAMINE_TRANSPORT,12,Down,0.927519073571607,0.980185831320829
777,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.927801012126514,0.980185831320829
778,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.927974503032744,0.980185831320829
779,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.928910903405019,0.980185831320829
780,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.930894758241381,0.981019860608224
781,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.93335413252197,0.981044966239951
782,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.934048208372276,0.981044966239951
783,WP_CORI_CYCLE,11,Down,0.934499037184771,0.981044966239951
784,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.937550118879299,0.981701197726538
785,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.940098146681718,0.981701197726538
786,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.940330565874837,0.981701197726538
787,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Up,0.941117157853506,0.981701197726538
788,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Up,0.942066062114411,0.981701197726538
789,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.942289835774012,0.981701197726538
790,WP_ALSTROM_SYNDROME,27,Down,0.943687167522987,0.98191247051126
791,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.946171446951762,0.982857905410668
792,WP_INSULIN_SIGNALING,129,Up,0.950660240107434,0.982857905410668
793,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.951443927470667,0.982857905410668
794,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.951457141729492,0.982857905410668
795,WP_SLEEP_REGULATION,11,Up,0.951724636835898,0.982857905410668
796,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.951769942465805,0.982857905410668
797,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.955082744354134,0.98321413448406
798,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.956055763584059,0.98321413448406
799,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.956712180836205,0.98321413448406
800,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Up,0.959608577014429,0.98321413448406
801,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.961346640143577,0.98321413448406
802,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.961638944442887,0.98321413448406
803,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.962206427670554,0.98321413448406
804,WP_EICOSANOID_SYNTHESIS,13,Up,0.964470542703512,0.98321413448406
805,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.964510854912181,0.98321413448406
806,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.964988123731336,0.98321413448406
807,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.965272270716103,0.98321413448406
808,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.970365163070605,0.986208924770954
809,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.971648607464589,0.986208924770954
810,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.972136991463327,0.986208924770954
811,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.97301148173874,0.986208924770954
812,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Down,0.976643464458463,0.988671093331104
813,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.979590029083784,0.990434199147442
814,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.985129307106389,0.994510683228342
815,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Down,0.986041614149756,0.994510683228342
816,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.988515593395383,0.995784090405643
817,WP_13Q1212_COPY_NUMBER_VARIATION,21,Down,0.994026308355321,0.998162438500367
818,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.994465603093558,0.998162438500367
819,WP_APOPTOSIS,72,Up,0.995492554814708,0.998162438500367
820,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.996305195690605,0.998162438500367
821,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.997001535291403,0.998162438500367
822,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.998162438500367,0.998162438500367
